Ballentine Partners’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,787
| Closed | -$56.4K | – | 646 |
|
|
2023
Q1 | $56.4K | Hold |
4,787
| – | – | ﹤0.01% | 558 |
|
|
2022
Q4 | $68.9K | Hold |
4,787
| – | – | ﹤0.01% | 497 |
|
|
2022
Q3 | $240K | Hold |
4,787
| – | – | 0.01% | 398 |
|
|
2022
Q2 | $408K | Hold |
4,787
| – | – | 0.01% | 268 |
|
|
2022
Q1 | $722K | Hold |
4,787
| – | – | 0.02% | 212 |
|
|
2021
Q4 | $1.43M | Hold |
4,787
| – | – | 0.04% | 142 |
|
|
2021
Q3 | $1.87M | Buy |
+4,787
| New | +$1.87M | 0.06% | 103 |
|